Advertisement
Skip to Content

Intelgenx Technologies Corp IGXT Stock Quote

| Rating as of

PINX: IGXT

Last close prices updated as of Feb 03, 2023, 3:38 PM EST | USD
  • Last Close 0.23045
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Growth
  • Day Range 0.22  –  0.24
  • Year Range 0.11  –  0.37
  • Market Cap 40.2472 Mil
  • Volume / Avg 62,900.0 /  86,381.2
  • Price / Sales 28.90
  • Price / Book 16.99
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis IGXT

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics IGXT

Company Profile IGXT

Business Description

Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.

Contact
6420 Abrams
Ville Saint Laurent, QC, H4S 1Y2, CAN
Industry Biotechnology
Employees 51

FAQs for Intelgenx Technologies Corp Stock

No. IGXT does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

IGXT’s market cap is 40.25 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

IGXT’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare IGXT’s historical performance against its industry peers and the overall market.